5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.36%
Revenue growth under 50% of VALMT.HE's 15.16%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-7.00%
Negative gross profit growth while VALMT.HE is at 28.38%. Joel Greenblatt would examine cost competitiveness or demand decline.
-22.32%
Negative EBIT growth while VALMT.HE is at 308.33%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-22.32%
Negative operating income growth while VALMT.HE is at 308.33%. Joel Greenblatt would press for urgent turnaround measures.
-22.45%
Negative net income growth while VALMT.HE stands at 337.50%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-20.00%
Negative EPS growth while VALMT.HE is at 360.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-20.00%
Negative diluted EPS growth while VALMT.HE is at 360.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-3.06%
Share reduction while VALMT.HE is at 1.62%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-3.06%
Reduced diluted shares while VALMT.HE is at 1.62%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
20.20%
Positive OCF growth while VALMT.HE is negative. John Neff would see this as a clear operational advantage vs. the competitor.
12.87%
Positive FCF growth while VALMT.HE is negative. John Neff would see a strong competitive edge in net cash generation.
-15.64%
Negative 10Y revenue/share CAGR while VALMT.HE stands at 55.17%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-13.13%
Negative 5Y CAGR while VALMT.HE stands at 55.17%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
4.03%
3Y revenue/share CAGR at 50-75% of VALMT.HE's 6.57%. Martin Whitman would question if the firm lags behind competitor innovations.
272.69%
10Y OCF/share CAGR above 1.5x VALMT.HE's 132.86%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
926.17%
5Y OCF/share CAGR above 1.5x VALMT.HE's 132.86%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
-31.90%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
141.86%
Below 50% of VALMT.HE's 2200.00%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
100.00%
Below 50% of VALMT.HE's 2200.00%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-20.00%
Negative 3Y CAGR while VALMT.HE is 64.14%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
22.37%
5Y equity/share CAGR at 50-75% of VALMT.HE's 31.58%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
22.73%
3Y equity/share CAGR above 1.5x VALMT.HE's 3.00%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
219.32%
Dividend/share CAGR of 219.32% while VALMT.HE is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
98.48%
3Y dividend/share CAGR at 75-90% of VALMT.HE's 118.26%. Bill Ackman wants overhead or revenue enhancements to match competitor's dividend growth.
8.31%
AR growth well above VALMT.HE's 7.19%. Michael Burry fears inflated revenue or higher default risk in the near future.
-3.36%
Inventory is declining while VALMT.HE stands at 5.13%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-6.39%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
6.92%
BV/share growth above 1.5x VALMT.HE's 0.42%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-21.68%
We’re deleveraging while VALMT.HE stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
6.22%
SG&A growth well above VALMT.HE's 4.58%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.